复方七芍降压片治疗高血压病的临床研究  

Clinical effect of Compound Qishao Jiangya Tablets on essential hypertension

作　　者：谭元生[1] 宋雪云[1] 谭胜真[1] 唐莹[1] 范愈记[1] 张稳[1] 

机构地区：[1]湖南中医学院第一附属医院,湖南长沙410007

出　　处：《中成药》2005年第7期795-798,共4页Chinese Traditional Patent Medicine

摘　　要：目的:探讨复方七芍降压片(三七,白芍,天麻等)治疗高血压病的临床疗效及作用机制。方法:采用随机单盲对照法设置治疗组与对照组,治疗组服用复方七芍降压片,对照组服用卡托普利。观察两组治疗前后血浆神经肽Y(NPY)的变化及血小板聚集率的变化。结果:两组均能降低血压及血浆NPY的含量,但无统计学意义;治疗组中医证候总有效率优于对照组;治疗组可降低血浆FIB的含量及改善血小板聚集率,治疗前后自身比较有统计学意义,而对照组则不显著。结论:复方七芍降压片对高血压病有较好的临床疗效且无明显毒副反应。AIM To observe the changes of plasma neuropeptide Y (NPY) levels in patients with essential hypertension(EH) taking Compound Qishao Jiangya Tablets (Radixet Rhizoma Notoginseng, Radix Paeoniae Alba, Rhizoma Gastrodiae, etc) and to investigate the significance of NPY in the pathogenesis of hypertension and the relationship between NPY and platelet disnormal function. METHODS The plasma NPY concentrations of 60 patients with EH and 20 normal ones were determined by radioimmunoassay, at the same time detected platelet aggregation rate and fibrinogen were detected. RESULTS The levels of plasma NPY in patients with EH were higher than that in normal control group. The NPY levels, the platelet aggregation rate, fibrinogen in the three periods of hypertension (period Ⅰ,Ⅱ, Ⅲ) were all significantly different and were increased with the severity of hypertension. CONCLUSION NPY may participate in the pathophysiological course of hypertension, and the plasma NPY, the platelet aggregation rate of the patients with EH were correlative. The plasma NPY should be dynamscally monitored in order to determine the disease degree. During the treatment for EH attention should be taken to decrease the platelet aggregation rate.

关 键 词：复方七芍降压片 高血压病 神经肽Y 血小板聚集率 纤维蛋白原 

分 类 号：R287[医药卫生—中药学]